$1.73 Billion is the total value of ARMISTICE CAPITAL, LLC's 71 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 92.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | Buy | ISHARES TRput | $231,938,000 | +155.4% | 14,000 | +133.3% | 13.38% | +122.3% |
SPY | Sell | SPDR S&P 500 ETF TRput | $193,116,000 | -18.7% | 6,000 | -25.0% | 11.14% | -29.2% |
CERC | CERECOR INC | $111,483,000 | +63.8% | 20,683,233 | 0.0% | 6.43% | +42.6% | |
AMAG | AMAG PHARMACEUTICALS INC | $49,410,000 | +5.4% | 4,060,000 | 0.0% | 2.85% | -8.3% | |
EPC | EDGEWELL PERS CARE COcall | $46,440,000 | -4.7% | 15,000 | 0.0% | 2.68% | -17.1% | |
VNDA | Sell | VANDA PHARMACEUTICALS INC | $46,407,000 | -1.5% | 2,828,000 | -20.3% | 2.68% | -14.3% |
SUPN | New | SUPERNUS PHARMACEUTICALS INC | $40,609,000 | – | 1,712,000 | +100.0% | 2.34% | – |
BIIB | Sell | BIOGEN INC | $37,981,000 | +10.2% | 128,000 | -13.5% | 2.19% | -4.1% |
REGN | Sell | REGENERON PHARMACEUTICALS | $37,548,000 | -8.5% | 100,000 | -32.4% | 2.17% | -20.4% |
PTCT | Buy | PTC THERAPEUTICS INC | $36,407,000 | +691.5% | 758,000 | +457.4% | 2.10% | +588.5% |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $33,317,000 | +38.2% | 612,000 | +5.9% | 1.92% | +20.3% |
WSM | New | WILLIAMS SONOMA INC | $32,843,000 | – | 447,206 | +100.0% | 1.90% | – |
BMY | New | BRISTOL MYERS SQUIBB CO | $32,095,000 | – | 500,000 | +100.0% | 1.85% | – |
DECK | New | DECKERS OUTDOOR CORP | $31,087,000 | – | 184,100 | +100.0% | 1.79% | – |
BLUE | New | BLUEBIRD BIO INC | $29,484,000 | – | 336,000 | +100.0% | 1.70% | – |
AZO | New | AUTOZONE INC | $29,367,000 | – | 24,651 | +100.0% | 1.69% | – |
CMG | Buy | CHIPOTLE MEXICAN GRILL INC | $28,246,000 | +12.0% | 33,742 | +12.5% | 1.63% | -2.5% |
DBX | Buy | DROPBOX INCcl a | $26,113,000 | +29.5% | 1,458,000 | +45.8% | 1.51% | +12.6% |
CENTA | New | CENTRAL GARDEN & PET COcl a non-vtg | $25,778,000 | – | 878,000 | +100.0% | 1.49% | – |
NVST | New | ENVISTA HLDGS CORP | $25,135,000 | – | 848,000 | +100.0% | 1.45% | – |
ENTA | Sell | ENANTA PHARMACEUTICALS INC | $24,335,000 | -30.2% | 393,895 | -32.1% | 1.40% | -39.2% |
INCY | Sell | INCYTE CORP | $24,013,000 | -24.4% | 275,000 | -35.7% | 1.38% | -34.2% |
FTDR | Buy | FRONTDOOR INC | $23,710,000 | +24.5% | 500,000 | +27.6% | 1.37% | +8.4% |
ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $23,652,000 | -2.5% | 1,156,000 | -53.2% | 1.36% | -15.2% |
AVYA | Buy | AVAYA HLDGS CORP | $22,842,000 | +329.4% | 1,692,000 | +225.4% | 1.32% | +273.4% |
VYGR | Buy | VOYAGER THERAPEUTICS INC | $22,655,000 | +20.1% | 1,624,000 | +48.2% | 1.31% | +4.6% |
KHC | Sell | KRAFT HEINZ CO | $22,170,000 | -47.1% | 690,000 | -54.0% | 1.28% | -53.9% |
EL | New | LAUDER ESTEE COS INCcl a | $20,654,000 | – | 100,000 | +100.0% | 1.19% | – |
QSR | Buy | RESTAURANT BRANDS INTL INC | $19,950,000 | +55.8% | 312,850 | +73.8% | 1.15% | +35.6% |
LULU | Sell | LULULEMON ATHLETICA INC | $19,391,000 | -25.4% | 83,700 | -38.0% | 1.12% | -35.1% |
CPRX | New | CATALYST PHARMACEUTICALS INC | $19,125,000 | – | 5,100,000 | +100.0% | 1.10% | – |
EYEG | EYEGATE PHARMACEUTICALS INC | $17,961,000 | +112.9% | 1,792,500 | 0.0% | 1.04% | +85.3% | |
RL | Sell | RALPH LAUREN CORPcl a | $17,837,000 | -19.5% | 152,168 | -34.4% | 1.03% | -29.9% |
MRTX | New | MIRATI THERAPEUTICS INC | $15,463,000 | – | 120,000 | +100.0% | 0.89% | – |
TWNK | Buy | HOSTESS BRANDS INCcl a | $14,947,000 | +84.3% | 1,028,000 | +77.2% | 0.86% | +60.2% |
QGEN | New | QIAGEN NV | $14,872,000 | – | 440,000 | +100.0% | 0.86% | – |
MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $14,578,000 | +56.6% | 160,000 | +48.1% | 0.84% | +36.3% |
ORLY | Sell | O REILLY AUTOMOTIVE INC NEW | $14,463,000 | -46.2% | 33,000 | -51.1% | 0.83% | -53.2% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $14,232,000 | +180.0% | 65,000 | +116.7% | 0.82% | +143.6% |
MNKKQ | MALLINCKRODT PUB LTD COcall | $13,960,000 | +44.8% | 40,000 | 0.0% | 0.80% | +26.0% | |
TJX | New | TJX COS INC NEW | $12,884,000 | – | 211,000 | +100.0% | 0.74% | – |
KSS | New | KOHLS CORP | $12,738,000 | – | 250,000 | +100.0% | 0.74% | – |
CPRI | New | CAPRI HOLDINGS LIMITED | $12,460,000 | – | 326,611 | +100.0% | 0.72% | – |
FIVE | New | FIVE BELOW INC | $11,566,000 | – | 90,457 | +100.0% | 0.67% | – |
WBT | Sell | WELBILT INC | $11,302,000 | -68.0% | 724,000 | -65.4% | 0.65% | -72.1% |
UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $11,274,000 | -38.5% | 128,000 | -44.3% | 0.65% | -46.5% |
BJ | New | BJS WHSL CLUB HLDGS INC | $10,818,000 | – | 475,746 | +100.0% | 0.62% | – |
MNKKQ | New | MALLINCKRODT PUB LTD CO | $9,346,000 | – | 2,678,000 | +100.0% | 0.54% | – |
PRTK | Buy | PARATEK PHARMACEUTICALS INC | $9,140,000 | +34.6% | 2,268,000 | +44.3% | 0.53% | +17.1% |
CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $9,014,000 | -16.7% | 148,000 | -43.9% | 0.52% | -27.5% |
TGTX | New | TG THERAPEUTICS INC | $8,880,000 | – | 800,000 | +100.0% | 0.51% | – |
VXRT | Buy | VAXART INC | $8,833,000 | +2.5% | 25,200,000 | +5.0% | 0.51% | -10.7% |
ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $8,323,000 | +203.5% | 2,196,000 | +309.7% | 0.48% | +163.7% |
TPR | New | TAPESTRY INC | $7,876,000 | – | 292,046 | +100.0% | 0.45% | – |
AYTU | Buy | AYTU BIOSCIENCE INC | $7,731,000 | +24.8% | 7,950,000 | +55.3% | 0.45% | +8.5% |
CI | New | CIGNA CORP NEW | $7,566,000 | – | 37,000 | +100.0% | 0.44% | – |
BIO | New | BIO RAD LABS INCcl a | $7,401,000 | – | 20,000 | +100.0% | 0.43% | – |
DNKN | New | DUNKIN BRANDS GROUP INC | $7,403,000 | – | 98,000 | +100.0% | 0.43% | – |
AMZN | Buy | AMAZON COM INC | $7,391,000 | +41.9% | 4,000 | +33.3% | 0.43% | +23.5% |
ALXN | New | ALEXION PHARMACEUTICALS INC | $7,354,000 | – | 68,000 | +100.0% | 0.42% | – |
MRK | Sell | MERCK & CO INC | $7,276,000 | -36.4% | 80,000 | -41.2% | 0.42% | -44.7% |
KMX | New | CARMAX INC | $7,189,000 | – | 82,000 | +100.0% | 0.42% | – |
OLLI | New | OLLIES BARGAIN OUTLT HLDGS I | $7,010,000 | – | 107,339 | +100.0% | 0.40% | – |
TORC | New | RESTORBIO INC | $5,251,000 | – | 3,524,000 | +100.0% | 0.30% | – |
NERV | New | MINERVA NEUROSCIENCES INC | $3,982,000 | – | 560,000 | +100.0% | 0.23% | – |
NNBR | New | NN INC | $2,701,000 | – | 292,021 | +100.0% | 0.16% | – |
New | ALIMERA SCIENCES INC | $2,577,000 | – | 340,000 | +100.0% | 0.15% | – | |
EKSO | New | EKSO BIONICS HLDGS INC | $1,218,000 | – | 3,114,399 | +100.0% | 0.07% | – |
MDGS | MEDIGUS LTDsponsored ads | $742,000 | -8.3% | 1,285,715 | 0.0% | 0.04% | -20.4% | |
TTPH | New | TETRAPHASE PHARMACEUTICALS I | $420,000 | – | 149,507 | +100.0% | 0.02% | – |
TROV | New | TROVAGENE INC | $103,000 | – | 82,928 | +100.0% | 0.01% | – |
BLPH | Exit | BELLEROPHON THERAPEUTICS INC | $0 | – | -885,000 | -100.0% | -0.03% | – |
AEZS | Exit | AETERNA ZENTARIS INC | $0 | – | -480,000 | -100.0% | -0.03% | – |
BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -1,034,962 | -100.0% | -0.07% | – |
DYNT | Exit | DYNATRONICS CORP | $0 | – | -536,000 | -100.0% | -0.09% | – |
VLRXQ | Exit | VALERITAS HLDGS INC | $0 | – | -1,060,000 | -100.0% | -0.10% | – |
SPHS | Exit | SOPHIRIS BIO INC | $0 | – | -1,793,666 | -100.0% | -0.15% | – |
CTXR | Exit | CITIUS PHARMACEUTICALS INC | $0 | – | -2,197,385 | -100.0% | -0.16% | – |
CPST | Exit | CAPSTONE TURBINE CORP | $0 | – | -835,000 | -100.0% | -0.18% | – |
ALIM | Exit | ALIMERA SCIENCES INC | $0 | – | -5,936,000 | -100.0% | -0.22% | – |
URBN | Exit | URBAN OUTFITTERS INC | $0 | – | -170,000 | -100.0% | -0.32% | – |
CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -20,000 | -100.0% | -0.52% | – |
LB | Exit | L BRANDS INC | $0 | – | -410,000 | -100.0% | -0.53% | – |
TSCO | Exit | TRACTOR SUPPLY CO | $0 | – | -108,000 | -100.0% | -0.65% | – |
ULTA | Exit | ULTA BEAUTY INC | $0 | – | -46,500 | -100.0% | -0.77% | – |
LOW | Exit | LOWES COS INC | $0 | – | -116,000 | -100.0% | -0.84% | – |
WING | Exit | WINGSTOP INC | $0 | – | -148,000 | -100.0% | -0.86% | – |
BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -636,000 | -100.0% | -1.18% | – |
ATRS | Exit | ANTARES PHARMA INC | $0 | – | -5,624,000 | -100.0% | -1.25% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -88,000 | -100.0% | -1.27% | – |
WEN | Exit | WENDYS CO | $0 | – | -1,000,000 | -100.0% | -1.32% | – |
ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -1.61% | – |
VFC | Exit | V F CORP | $0 | – | -285,000 | -100.0% | -1.68% | – |
TGT | Exit | TARGET CORP | $0 | – | -240,000 | -100.0% | -1.70% | – |
DPLO | Exit | DIPLOMAT PHARMACY INC | $0 | – | -5,400,000 | -100.0% | -1.75% | – |
FL | Exit | FOOT LOCKER INC | $0 | – | -615,000 | -100.0% | -1.76% | – |
ENR | Exit | ENERGIZER HLDGS INC NEW | $0 | – | -800,000 | -100.0% | -2.31% | – |
HAIN | Exit | HAIN CELESTIAL GROUP INCcall | $0 | – | -17,000 | -100.0% | -2.42% | – |
CELG | Exit | CELGENE CORP | $0 | – | -512,000 | -100.0% | -3.37% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
INCYTE CORP | 21 | Q3 2023 | 2.8% |
VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.